###begin article-title 0
###xml 112 119 112 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
Selective Deletion of the A1 Adenosine Receptor Abolishes Heart-Rate Slowing Effects of Intravascular Adenosine In Vivo
###end article-title 0
###begin p 1
Conceived and designed the experiments: MK TE HKE. Performed the experiments: MK TE. Analyzed the data: MK TE HKE. Wrote the paper: MK HKE.
###end p 1
###begin title 2
Objective
###end title 2
###begin p 3
Intravenous adenosine induces temporary bradycardia. This is due to the activation of extracellular adenosine receptors (ARs). While adenosine can signal through any of four ARs (A1AR, A2AAR, A2BAR, A3AR), previous ex vivo studies implicated the A1AR in the heart-rate slowing effects. Here, we used comparative genetic in vivo studies to address the contribution of individual ARs to the heart-rate slowing effects of intravascular adenosine.
###end p 3
###begin title 4
Methods and Results
###end title 4
###begin p 5
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 402 410 402 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 417 420 417 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 412 420 412 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 425 432 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR<sup>&#8722;/&#8722;</sup></italic>
###xml 530 533 530 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 526 533 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 678 681 678 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 673 681 673 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 691 694 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 686 694 686 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 748 751 748 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 744 751 744 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
We studied gene-targeted mice for individual ARs to define their in vivo contribution to the heart-rate slowing effects of adenosine. Anesthetized mice were treated with a bolus of intravascular adenosine, followed by measurements of heart-rate and blood pressure via a carotid artery catheter. These studies demonstrated dose-dependent slowing of the heart rate with adenosine treatment in wild-type, A2AAR-/-, A2BAR-/-, or A3AR-/- mice. In contrast, adenosine-dependent slowing of the heart-rate was completely abolished in A1AR-/- mice. Moreover, pre-treatment with a specific A1AR antagonist (DPCPX) attenuated the heart-rate slowing effects of adenosine in wild-type, A2AAR-/-, or A2BAR-/- mice, but did not alter hemodynamic responses of A1AR-/- mice.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
The present studies combine pharmacological and genetic in vivo evidence for a selective role of the A1AR in slowing the heart rate during adenosine bolus injection.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Drury1">[1]</xref>
###xml 501 504 501 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Drury1">[1]</xref>
###xml 616 619 616 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Drury1">[1]</xref>
###xml 708 711 708 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Belhassen1">[2]</xref>
###xml 836 839 836 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Delacretaz1">[3]</xref>
###xml 665 673 <span type="species:ncbi:9606">patients</span>
The first published observation that intravascular adenosine causes a temporary heart block dates back to 1927, when Drury and Szent-Gyorgyi from the University of Cambridge, United Kingdom, injected extracts from cardiac tissues intravenously into a whole animal. They noticed a transient decrease of the cardiac rhythm and slowing of the heart rate [1]. Following several purification steps, the authors were able to identify the biologically active compound of the extract as an "adenine compound" [1]. It took almost 50 years from these early discoveries of the heart-rate-slowing effects of "adenine compounds" [1] to the clinical use of adenosine in treating patients with supraventricular tachycardia [2]. As of today, intravenous adenosine has remained a mainstay therapy for diagnosing or treating supraventricular arrhythmias [3].
###end p 9
###begin p 10
###xml 109 112 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Fredholm1">[4]</xref>
###xml 534 538 534 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KAdo</sub>
###xml 540 543 540 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-West1">[5]</xref>
###xml 545 548 545 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Belardinelli1">[6]</xref>
###xml 550 553 550 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Belardinelli2">[7]</xref>
###xml 751 752 748 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 803 806 800 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Olsson1">[8]</xref>
###xml 1033 1036 1030 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Reichelt1">[9]</xref>
Adenosine mediates its signaling effects through 4 adenosine receptors (ARs): A1AR, A2AR, A2BAR and the A3AR [4]. Previous studies implicated the A1AR in the heart-rate slowing effects of adenosine. This is based on direct and indirect effects associated with the activation of cardiac A1ARs. Direct A1AR signaling effects are thought to lead to a hyperpolarization of sinus node cells as well as cells of the arterioventricular node (AV node) primarily by inducing a potassium current through an inward rectifier potassium channel (IKAdo) [5], [6], [7]. Indirect effects of adenosine signaling on the heart rate may involve the ability of the A1AR to induce an "anti-adrenergic" state by opposing the effect of sympathetic nervous activation and beta1-stimulation by lowering intracellular cAMP levels [8]. Based on these finding it was concluded that the A1AR causes the adenosine induced bradycardia. However, these studies are limited to observations based on pharmacologic or genetic in vitro studies in a Langendorff apparatus [9]. At present, comparative genetic in vivo studies have yet to confirm the selective role of the A1AR in adenosine-mediated bradycardia.
###end p 10
###begin p 11
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
To elucidate the contribution of individual ARs to adenosine-induced bradycardia in vivo, we utilized mice with specific deletions of each individual AR. In addition, we confirmed our findings utilizing pharmacological approaches in wild-type or gene-targeted mice for ARs. Consistent with previous ex vivo studies, we found a selective role for the A1AR in adenosine-mediated bradycardia in vivo.
###end p 11
###begin title 12
Materials and Methods
###end title 12
###begin title 13
Ethics Statement
###end title 13
###begin p 14
All animals were handled in strict accordance with good animal practice as defined by the relevant national and/or local animal welfare bodies. All experiments were in accordance with the University of Colorado Denver guidelines for animal care and are approved by the Institutional Animal Care and Use Committee at the University of Colorado Denver.
###end p 14
###begin title 15
Animals, Heart Rate and Arterial Pressure Measurements
###end title 15
###begin p 16
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Sun1">[10]</xref>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BA <sup>&#8722;/&#8722;</sup></italic>
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eckle1">[11]</xref>
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 97 108 97 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">or A3AR <sup>&#8722;/&#8722;</sup></italic>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Salvatore1">[12]</xref>
###xml 146 149 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AR<sup>&#8722;/&#8722;</sup></italic>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Ledent1">[13]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eckle2">[14]</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Koeppen1">[15]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Siegl1">[16]</xref>
###xml 528 531 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">Mice</span>
###xml 651 656 <span type="species:ncbi:10090">mouse</span>
###xml 1245 1249 <span type="species:ncbi:10090">mice</span>
Experiments were performed in 12- to 14-week-old, previously described, A1AR-/-[10], A2BA -/-[11]or A3AR -/-[12] on the C57BL/6 strain and in A2AR-/-[13] on the CD1 strain or littermate controls matched in age, gender and weight. In addition, studies in wild-type mice were carried out in C57BL/6. Mice were anesthetized, intubated and mechanical ventilated as described previously [14]. A polyethelene catheter was inserted in the right carotid artery as described previously [15], [16]. The catheter was connected to a Deltran(R) pressure transducer (Utah Medical Products Inc., Salt Lake City, UT, USA) located at the same hydrostatic level as the mouse, which was connected to the CyQ BMP02 system (CyberSense, Inc., Nicholasville, KY, USA) designed to measure invasively systolic, diastolic, pulse pressure, mean arterial blood pressure (MAP) and heart rate (HR). Due to a sampling rate of 1,000 Hz, the device automatically calculates HR from the amplitude of the pressure signal. To correct HR measurement by the BMP02 for movement artifact etc. an electrocardiogram (ECG) monitor (Hewlett-Packard, Boblingen, Germany) was connected throughout the experiments. Adenosine was given via the arterial catheter in a volume of 100 microL. All mice were euthanized following the experimental protocol utilizing a lethal dose of pentobarbital followed by cervical dislocation.
###end p 16
###begin title 17
Pharmacological Compounds
###end title 17
###begin p 18
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Grenz1">[17]</xref>
Adenosine was dissolved in 0.9% NaCl solution (1 mg/ml). DPCPX was dissolved in Ethanol (stock solution10 mmol/l). All solutions were prepared on the day of the experiment. DPCPX was applied by i.p. injection in dose of 1 mg/kg 30 min prior to adenosine treatment. This dose of DPCPX was described previously to sufficiently block A1AR [17]. All substances were purchased from Sigma-Aldrich.
###end p 18
###begin title 19
Data Analysis and Calculation
###end title 19
###begin p 20
###xml 341 342 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 410 411 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 644 647 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 658 661 654 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
The mean of HR and MAP at 30 s prior to the injection of drugs were taken as baseline values. The lowest value after drug injection was taken as the minimum (HR or MAP). The percentage of maximal change of HR and MAP was calculated using the formula: Percent change = Minimum/Baseline*100. Data were compared by 2-factor ANOVA or by Student t test when appropriate. Data are expressed as mean+/-SEM. Values of P<0.05 were considered statistically significant. For statistical analyses, GraphPad Prism 5.0 software for Windows XP (GraphPad Software, San Diego, Calif) was used, calculation of percentage of change were performed using Excel 2007(R) (Microsoft(R), Redmond, WA, USA).
###end p 20
###begin p 21
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
###xml 10 14 <span type="species:ncbi:10090">mice</span>
Wild type mice show decrease heart rate and mean arterial pressure in response to adenosine bolus injection
###end title 23
###begin p 24
###xml 449 457 449 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006784-g001">Figure 1</xref>
###xml 728 737 720 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006784-g002">Figure 2A</xref>
###xml 759 768 751 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006784-g002">Figure 2B</xref>
###xml 957 966 945 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006784-g002">Figure 2C</xref>
###xml 988 997 976 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006784-g002">Figure 2D</xref>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 1199 1205 <span type="species:ncbi:10090">murine</span>
###xml 1288 1296 <span type="species:ncbi:9606">patients</span>
Results from previous studies suggest that adenosine induces bradycardia by activation of A1AR. This is based on pharmacologic or genetic ex vivo studies. However, comparative in vivo studies on the heart-rate slowing effects of adenosine in gene-targeted mice for individual ARs have not been performed. To study the effects of vascular adenosine injection on the heart-rate, we inserted a polyethylene catheter into the common carotid artery (see Figure 1). Next, we injected 25, 50 microg or 100 microg of adenosine via the carotid artery catheter. Higher doses of adenosine were also tested, however did not show additional effects on the heart-rate (data no shown). Adenosine caused a dose dependent decline in heart rate (Figure 2A) and blood pressure (Figure 2B). With increasing doses, magnitude and duration of the response increased. Injection of a corresponding volume of vehicle solution (150 microl normal saline) also caused a decrease in HR (Figure 2C) and blood pressure (Figure 2D), however to a much smaller extent than adenosine. Taken together, these data show that intravascular bolus injection of adenosine is associated with a dose-dependent slowing of the heart rate in this murine model system, consistent with the notion of adenosine-induced heart block seen in patients following adenosine-treatment of supraventricular tachycardia.
###end p 24
###begin title 25
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Invasive measurement of hemodynamic parameters in mice.
###end title 25
###begin p 26
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Mice were anesthetized with pentobarbital, mechanical ventilation was instituted and mice were ventilated using pressure-controlled settings (inspiratory pressure of 15 mbar, positive end-exspiratory pressure 5 mbar, 60% inspired oxygen concentration). The common carotid artery was cannulated utilizing a polyethylene tube. The arterial catheter was connected to a pressure transducer which automatically calculated the HR by analyzing the amplitude of the pressure signal. For verification of heart measurements, an electrocardiogram (ECG) monitor was connected throughout the experiment. Values were recorded to computer hard drive for further analysis.
###end p 26
###begin title 27
Changes of blood pressure and heart-rate following vascular adenosine injection.
###end title 27
###begin p 28
###xml 358 361 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">: *</italic>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
Following insertion of a catheter into the common carotid artery, mean arterial blood pressure and heart rate were measured. Intravascular bolus injection of adenosine as indicated. (A, B) Wild type mice received vehicle (normal saline) or adenosine at indicated doses (100 microl). (C, D) Relative change in mean arterial blood pressure or heart-rate. (A, B: *p<0.05; n = 8; mean+/-SEM).
###end p 28
###begin title 29
Genetic deletion of the A1AR abolishes adenosine-induced slowing of the heart-rate
###end title 29
###begin p 30
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR</italic>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Sun1">[10]</xref>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR</italic>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006784-g003">Figure 3</xref>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR</italic>
###xml 27 33 <span type="species:ncbi:10090">murine</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
After having established a murine model for studying adenosine-mediated slowing of the heart rate in vivo, we next assessed the contribution of individual ARs. Based on studies indicating A1AR signaling in the negative chronotropic effects of adenosine, we first pursued studies in previously characterized mice gene-targeted for the A1AR[10]. In contrast to our findings in wild-type mice, the heart-rate slowing effect of vascular adenosine infection was abolished in gene-targeted mice for the A1AR (Figure 3). Taken together, these studies provide genetic in vivo evidence for the A1AR in the heart-rate slowing effects of vascular adenosine.
###end p 30
###begin title 31
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Adenosine bolus injections in gene-targeted mice for the A1AR.
###end title 31
###begin p 32
###xml 128 131 128 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 435 438 427 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 543 546 535 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 425 606 417 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note: A1AR<sup>&#8722;/&#8722;</sup>-mice experience no change in HR following bolus injection of adenosine. (n&#8202;=&#8202;7&#8211;8; WT n&#8202;=&#8202;8, *p&lt;0.05 A1AR<sup>&#8722;/&#8722;</sup> vs WT; #p&lt;0.05 compared to adenosine-vehicle; mean&#177;SEM;).</italic>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
Following insertion of a catheter into the common carotid artery, mean arterial blood pressure and heart rate were measured A1AR-/--mice received bolus injection of vehicle or indicated doses of adenosine (100 microl) via the carotid artery catheter. (A, B) Heart-rate and blood pressure responses to 100 microg of adenosine compared to wild type mice. (C, D) Relative changes in heart-rate and mean arterial blood pressure. Note: A1AR-/--mice experience no change in HR following bolus injection of adenosine. (n = 7-8; WT n = 8, *p<0.05 A1AR-/- vs WT; #p<0.05 compared to adenosine-vehicle; mean+/-SEM;).
###end p 32
###begin title 33
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Negative chronotropic effects of vascular adenosine are maintained in mice gene targeted for A2AAR, A2BAR or A3AR
###end title 33
###begin p 34
###xml 56 60 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eckle1">[11]</xref>
###xml 214 217 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 209 217 209 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 219 227 219 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 235 238 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 231 238 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR<sup>&#8722;/&#8722;</sup></italic>
###xml 302 310 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006784-g004">Figure 4</xref>
###xml 602 606 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eckle1">[11]</xref>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eckle3">[18]</xref>
###xml 33 39 <span type="species:ncbi:10090">murine</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
Since all 4 ARs are expressed in murine cardiac tissues [11], we next studied the contribution of other ARs to the heart-rate slowing effects induced by adenosine bolus injection. For this purpose, we treated A2AAR-/-, A2BAR-/- or A3AR-/- with incremental doses of intravascular adenosine. As shown in Figure 4, the heart rate decreased in all tested genotypes to a similar degree. In fact, we observed no difference between gene-targeted mice or their corresponding littermate controls. These studies provide genetic evidence that even though the A2AAR, A2BAR or A3AR are expressed on cardiac tissues [11], [18], they do not mediate the heart-rate slowing effects of adenosine.
###end p 34
###begin title 35
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Effect of systemic adenosine administration in AR gene targeted mice.
###end title 35
###begin p 36
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 140 143 140 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 135 143 135 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR<sup>&#8722;/&#8722;</sup></italic>
###xml 355 358 351 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 350 358 346 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 371 374 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 366 374 362 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 386 389 382 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 382 451 378 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR<sup>&#8722;/&#8722;</sup> (n&#8202;=&#8202;6&#8211;8, *p&lt;0.05 compared to adenosine-vehicle; mean&#177;SEM).</italic>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
Following insertion of a catheter into the common carotid artery, mean arterial blood pressure and heart rate were measured. A2AAR-/-, A2BAR-/- orA3AR-/- received bolus injections of vehicle solution or indicated doses of adenosine in 100 microl of vehicle. Change in heart-rate and mean arterial pressure compared to littermate control mice. (A, B) A2AAR-/- (C, D) A2BAR-/- (E, F) A3AR-/- (n = 6-8, *p<0.05 compared to adenosine-vehicle; mean+/-SEM).
###end p 36
###begin title 37
###xml 74 78 <span type="species:ncbi:10090">mice</span>
A1AR inhibitor DPCPX abrogates adenosine-induced bradycardia in wild-type mice
###end title 37
###begin p 38
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Grenz1">[17]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Fredholm2">[19]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Johansson1">[20]</xref>
###xml 449 464 449 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006784-g005">Figure 5A and B</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
The data gathered so far suggest that the A1AR plays an important role in hemodynamic responses to systemic adenosine. In order to circumvent possible adaptive mechanisms that might be present in gene targeted mice (biological compensation), we next sought to further characterize the role of A1AR using a pharmacological approach. Here we utilized the effect of the selective A1AR inhibitor DPCPX (1 mg/kg i.p.) in wild type mice [17], [19], [20]. Figure 5A and B show that bradycardia to systemic adenosine is strongly attenuated following the administration of DPCPX. Taken together, such studies suggest that pharmacological inhibition - similar to genetic deletion - of the A1AR dampens adenosine-dependent heart-rate responses in vivo.
###end p 38
###begin title 39
Effect of A1AR antagonist DPCPX on adenosine-induced slowing of the heart-rate.
###end title 39
###begin p 40
###xml 474 601 470 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(n&#8202;=&#8202;4, * indicates p&lt;0.05 compared to DPCPX treatment; #indicates p&lt;0.05 compared to adenosine-vehicle injection; mean&#177;SEM).</italic>
Following insertion of a catheter into the common carotid artery, mean arterial blood pressure and heart rate were measured after injection of vehicle or adenosine at indicated doses (volume of 100 microl). All animals received 1 mg/kg of the A1AR antagonist DPCPX (i.p., 30 min prior to the experimental procedure) or vehicle. (A, B) Heart-rate or mean arterial blood pressure at indicated time points. (C, D) Relative changes of heart-rate or mean arterial blood pressure (n = 4, * indicates p<0.05 compared to DPCPX treatment; #indicates p<0.05 compared to adenosine-vehicle injection; mean+/-SEM).
###end p 40
###begin title 41
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
DPCPX attenuates bradycardia in AR gene targeted mice, except A1AR-/- mice
###end title 41
###begin p 42
###xml 189 197 189 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006784-g006">Figure 6</xref>
###xml 291 294 291 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 286 294 286 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 304 307 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 299 307 299 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 354 357 354 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
To further study the influence of A1AR on hemodynamic responses to adenosine, we next investigated the effect of the A1AR antagonist DPCPX in mice with genetic deletion of ARs. As shown in Figure 6, treatment with DPCPX prevented bradycardia after systemic adenosine bolus injection in A2AAR-/- and A2BAR-/- mice. As expected, DPCPX had no effect in A1AR-/- mice. Taken together these studies suggest selectivity of DPCPX for the A1AR, and confirm our genetic studies that adenosine-mediated slowing of the heart-rate is selectively mediated by the A1AR.
###end p 42
###begin title 43
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Effect of A1 adenosine receptor (AR) antagonist DPCPX in AR gene targeted mice.
###end title 43
###begin p 44
###xml 386 389 382 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 381 389 377 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 402 405 398 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 397 405 393 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 418 421 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 413 521 409 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup> (n&#8202;=&#8202;4;* p&lt;0.05 compared to DPCPX treated mice; #p&lt;0.05 compared to adenosine-vehicle; mean&#177;SEM).</italic>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
Following insertion of a catheter into the common carotid artery, mean arterial blood pressure and heart rate were measured after injection of vehicle or adenosine at indicated doses (volume of 100 microl). All animals received 1 mg/kg of the A1AR antagonist DPCPX (i.p., 30 min prior to the experimental procedure) or vehicle. Relative changes in HR and MAP are displayed. (A, B) A1AAR-/- (C, D) A2AAR-/- (E, F) A2BAR-/- (n = 4;* p<0.05 compared to DPCPX treated mice; #p<0.05 compared to adenosine-vehicle; mean+/-SEM).
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Sitkovsky1">[21]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eltzschig1">[22]</xref>
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Fredholm1">[4]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Rosenberger1">[23]</xref>
###xml 414 417 414 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Fredholm1">[4]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eckle3">[18]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eckle4">[24]</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eltzschig2">[25]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Eckle5">[26]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Ohta1">[27]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Sitkovsky2">[28]</xref>
###xml 958 962 958 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR</italic>
###xml 1051 1054 1051 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1046 1054 1046 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1061 1064 1061 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1056 1064 1056 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1072 1075 1072 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1068 1075 1068 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR<sup>&#8722;/&#8722;</sup></italic>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
###xml 1076 1080 <span type="species:ncbi:10090">mice</span>
Extracellular adenosine represents an endogenous distress signal, particularly generated under injurious conditions such as hypoxia or ischemia [21], [22]. Under such circumstances, extracellular adenosine signaling plays a critical role in attenuating hypoxia-induced tissue injury and inflammation [4], [23]. It elicits its signaling effects through any of four ARs, which are highly conserved among vertebrates [4]. In addition to its role in hypoxia-adaptation [18], [24], [25] and attenuation of inflammation [26], [27], [28], adenosine is known to cause significant slowing of the heart rate, when injected intravenously. In this study, we investigated the contribution of different ARs to the heart-rate slowing effects of vascular adenosine utilizing genetic and pharmacological in vivo approaches. We found that adenosine caused a dose dependent decrease in heart rate in wild type mice, which was completely abolished in gene-targeted mice for the A1AR or following pre-treatment with the A1AR antagonist DPCPX. In contrast, studies in A2AAR-/-, A2BAR-/- or A3AR-/- mice demonstrated heart-rate slowing following vascular adenosine injection, suggesting a high degree of selectivity for the A1AR-mediated role in slowing of the heart-rate.
###end p 46
###begin p 47
###xml 706 711 706 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR</italic>
###xml 711 715 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Ledent1">[13]</xref>
###xml 745 748 745 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 740 748 740 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Ledent1">[13]</xref>
###xml 1094 1098 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Huang1">[29]</xref>
###xml 1391 1395 1391 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang1">[30]</xref>
###xml 1537 1541 1537 1541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR</italic>
###xml 1545 1550 1545 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR</italic>
###xml 1695 1698 1695 1698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1691 1698 1691 1698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 1722 1725 1722 1725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1717 1725 1717 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 2258 2262 2258 2262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang1">[30]</xref>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 924 928 <span type="species:ncbi:10090">mice</span>
###xml 1373 1377 <span type="species:ncbi:10090">mice</span>
###xml 1505 1509 <span type="species:ncbi:10090">mice</span>
###xml 1699 1703 <span type="species:ncbi:10090">mice</span>
###xml 1726 1730 <span type="species:ncbi:10090">mice</span>
The present studies closely relate to studies of central nervous system (CNS) adenosine signaling in the regulation of blood pressure, temperature and sleep-awake cycle. Of particular interest has been the non-specific adenosine receptor antagonist caffeine. As such, caffeine is a CNS stimulant, having the effect of temporarily warding off drowsiness, restoring alertness and elevating blood pressure and heart-rate. In fact, caffeine is the world's most widely consumed psychoactive substance. The question through which adenosine receptors the stimulating effects of caffeine are mediated has been the center of several research studies. First evidence comes from studies in gene-targeted mice for the A2AAR[13]. The authors found that A2AAR-/- mice showed attenuated exploratory activity, whereas caffeine, which normally stimulates exploratory behavior, became a depressant of exploratory activity. In addition, these mice had higher blood pressure and increased heart-rate [13]. A second study in genetic models confirmed that caffeine mediated arousal involves the A2A and not the A1AR [29]. Only recently, a very elegant and complete study from the research group of Bertil Fredholm extended these findings towards the physiological contributions of A1 and A2A receptors in the regulation of heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine [30]. Here, the authors studied heart rate, body temperature, locomotor activity, and oxygen consumption in awake mice lacking one or both of the A1AR or A2AAR using telemetry and respirometry, before and after caffeine administration. When compared with wild-type littermates, HR was higher in male A1AR-/- mice but lower in A2AAR-/- mice. A single dose of an unselective beta-blocker abolished the HR differences between these genotypes, thus indicating that the studied differences involve central nervous system mediated alterations of heart rate and blood pressure. Taken together, these studies indicate that the A2AAR plays an important role in the modulation of oxygen comsumption, locomoter activity by acute and chronic caffeine administration. There is also evidence for effects of higher doses of caffeine being independent of both the A1AR and the A2AAR [30].
###end p 47
###begin p 48
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang2">[31]</xref>
###xml 468 471 468 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 464 471 464 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 617 620 617 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 613 620 613 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 743 746 743 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 739 746 739 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 843 846 843 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Reichelt1">[9]</xref>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
Consistent with our studies indicating a role of the A1AR in mediating acute responses to adenosine bolus injections, other studies from Bertil Fredholm's group indicated that the A1AR is involved in the regulation of heart rate, body temperature and locomotor activity, but the magnitude of the involvement is different in males and females [31]. Female mice had higher heart rate, body temperature and locomotion, both during daytime and during the night. Awake A1AR-/- mice had a slightly elevated heart rate, and this was more clear-cut in males. Heart rate was also higher in Langendorff-perfused denervated A1AR-/- hearts. Futhermore the bradycardic response to the adenosine receptor agonist 2-chloroadenosine is absent in isolated A1AR-/- hearts, which was demonstrated in very elegant studies from the research group of John Headrick [9]. At present it remains somewhat unclear how the central and peripheral mechanisms of adenosine receptor dependent regulation of blood pressure and heart rate act in concert.
###end p 48
###begin p 49
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang1">[30]</xref>
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang2">[31]</xref>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang1">[30]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang2">[31]</xref>
###xml 817 820 817 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Delacretaz1">[3]</xref>
###xml 1053 1057 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang1">[30]</xref>
###xml 1059 1063 1059 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang2">[31]</xref>
###xml 1100 1104 1100 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang2">[31]</xref>
###xml 755 763 <span type="species:ncbi:9606">patients</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
While there is some overlap between these studies of Bertil Fredholm's group [30], [31] and our present data, the main differences between both studies are the mechanisms of adenosine receptor mediated alterations in blood pressure, heart rate and locomotion. While the studies above mainly focus on the consequences of caffeine - a CNS stimulant that works through inhibition of CNS adenosine receptors [30] or at baseline heart rate levels without adenosine stimulation [31] - the present studies address the role of peripheral adenosine receptors located in the heart in mediating adenosine-dependent slowing of the hear-rate following intravascular adenosine injection. In fact, intravascular injection of adenosine is performed on a routine basis in patients during the treatment of supraventricular tachycardia [3]. As such, the present studies were performed in an in vivo setting following a time interval of 30 s after adenosine receptor activation, while the studies of Bertil Fredholm's group examined non-anesthetized mice over several days [30], [31], or ex vivo Langendorf preparations [31].
###end p 49
###begin p 50
###xml 187 190 187 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Belardinelli1">[6]</xref>
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Belardinelli2">[7]</xref>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Rivkees1">[32]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang2">[31]</xref>
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Linden1">[33]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Kapicka1">[34]</xref>
###xml 542 546 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Hasko1">[35]</xref>
###xml 604 605 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 684 687 681 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Olsson1">[8]</xref>
###xml 904 908 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Headrick1">[36]</xref>
###xml 910 914 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Gauthier1">[37]</xref>
###xml 1045 1049 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Matherne1">[38]</xref>
###xml 1399 1403 1390 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Bertolet1">[39]</xref>
###xml 1528 1535 1519 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1626 1630 1617 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Johansson1">[20]</xref>
###xml 1666 1669 1657 1660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1662 1669 1653 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 1767 1771 1758 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang2">[31]</xref>
###xml 1886 1889 1877 1880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1882 1889 1873 1880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 2114 2117 2105 2108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2110 2117 2101 2108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 2246 2250 2237 2241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yang1">[30]</xref>
###xml 701 716 <span type="species:ncbi:10090">transgenic mice</span>
###xml 899 903 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
###xml 1173 1181 <span type="species:ncbi:9606">patients</span>
###xml 1575 1579 <span type="species:ncbi:10090">mice</span>
###xml 1670 1674 <span type="species:ncbi:10090">mice</span>
###xml 1762 1766 <span type="species:ncbi:10090">mice</span>
###xml 1810 1814 <span type="species:ncbi:10090">mice</span>
###xml 1890 1894 <span type="species:ncbi:10090">mice</span>
###xml 2118 2122 <span type="species:ncbi:10090">mice</span>
Previous studies had shown that the A1AR can influences the ion current in cardiac pacemakers, causing slower atrioventricular nodal conduction, causing bradycardia as seen in this study [6], [7]. The A1AR promoter is highly active in the atrium [32], leading to high A1AR mRNA levels [31]. In fact, expressional levels of the A1AR are higher in the atrium as compared to the ventricle [33], [34]. Furthermore, activation of A1AR by adenosine causes an inhibition of adenylate cyclase, which results in decreased intracellular levels of cAMP [35]. Thus, A1AR activation counteracts the effect of the beta1-adrenoceptor, which activates the adenylate cylcase and increases cAMP levels [8]. In fact, in transgenic mice, overexpressing the A1AR, it was shown that the beta-adrenoceptor sensitivity/reactivity was impaired, despite the fact, that there is an enhanced beta-adrenoceptor density in these mice [36], [37]. Moreover, isolated perfused hearts from A1AR overexpressing mice had a lower resting heart rate when compared to control animals [38]. Similarly, previous studies hypothesized that the activation of the A1AR may also be a potential cause for bradycardia in patients following cardiac transplantation. In fact, these studies showed that administration of the unspecific adenosine receptor antagonist theophylline leads normalization of the heart rate in cardiac transplant recepients [39]. However, as of to date it seems unclear whether the A1AR has an influence on the heart rate under physiological conditions in vivo. There are reports that A1AR deficient mice have similar heart-rate as wild type controls [20]. In contrast, when hearts from A1AR-/- mice are isolated, the heart rate measurements reveal a higher heart-rate than in wild-type mice [31]. In the current study in anesthetized mice, we did not see a difference in baseline heart-rate when comparing A1AR-/- mice to littermate controls. However, since anesthesia sufficiently blocks the influence of sympathetic nervous system on the heart, we cannot draw conclusion on the HR in the alert state. Other reports stated that male A1AR-/- mice have a higher heart rate than wild type littermates, suggesting that gender might influence A1AR function of regulating HR [30].
###end p 50
###begin p 51
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Ledent1">[13]</xref>
###xml 247 250 247 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 242 250 242 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Barraco1">[40]</xref>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
Other ARs have also been suggested to influence the heart rate in mice. A2AAR-/- deficient mice have a higher blood pressure and heart rate when compared to wild type mice [13]. In the present study the response to intravascular adenosine of A2AAR-/- mice was not altered when compared to that of littermate controls. These findings suggest that the A2AAR does not influence the cardiac conductance system directly in response to systemic adenosine. It seems plausible that A2AAR, rather, influences HR via central nervous system mediated mechanisms [40].
###end p 51
###begin p 52
###xml 814 818 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Yilmaz1">[41]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Thengchaisri1">[42]</xref>
###xml 826 830 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Nicholls1">[43]</xref>
###xml 832 836 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Keddie1">[44]</xref>
Systemic adenosine, as used in present studies could simultaneously influence two important variables of the blood pressure: cardiac output and vascular resistance. In the present study the intravascular administration of adenosine leads to a decrease in the mean arterial pressure, simultaneously with the observed slowing of the heart-rate. It is important to point out that from the current data, it is difficult to conclude which AR might mediate the decrease in MAP (adenosine-mediated vasodilatation). Both variables (HR and MAP) were altered simultaneously in the experimental protocol. Various studies have assessed the influence of ARs on arterioles and different adenosine receptors might be involved in arteriolar dilatations, however there is evidence that the A2AAR might play the most important role [41], [42], [43], [44].
###end p 52
###begin p 53
###xml 120 127 120 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006784-Belardinelli2">[7]</xref>
Taken together, the present studies reveal a critical role of the A1AR to adenosine bolus injection induced bradycardia in vivo. A2AAR, A2BAR and A3AR [7] do not influence the response to intravascular adenosine.
###end p 53
###begin title 54
References
###end title 54
###begin article-title 55
The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart.
###end article-title 55
###begin article-title 56
Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: clinical and experimental aspects.
###end article-title 56
###begin article-title 57
Clinical practice. Supraventricular tachycardia.
###end article-title 57
###begin article-title 58
Adenosine, an endogenous distress signal, modulates tissue damage and repair.
###end article-title 58
###begin article-title 59
Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node.
###end article-title 59
###begin article-title 60
Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes.
###end article-title 60
###begin article-title 61
###xml 62 68 <span type="species:ncbi:9986">rabbit</span>
Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart.
###end article-title 61
###begin article-title 62
Cardiovascular purinoceptors.
###end article-title 62
###begin article-title 63
Genetic deletion of the A1 adenosine receptor limits myocardial ischemic tolerance.
###end article-title 63
###begin article-title 64
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors.
###end article-title 64
###begin article-title 65
Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.
###end article-title 65
###begin article-title 66
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells.
###end article-title 66
###begin article-title 67
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.
###end article-title 67
###begin article-title 68
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice.
###end article-title 68
###begin article-title 69
cGMP-dependent protein kinase mediates NO- but not acetylcholine-induced dilations in resistance vessels in vivo.
###end article-title 69
###begin article-title 70
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Myoendothelial coupling is not prominent in arterioles within the mouse cremaster microcirculation in vivo.
###end article-title 70
###begin article-title 71
Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia.
###end article-title 71
###begin article-title 72
Hypoxia-Inducible Factor-1 Is Central to Cardioprotection: A New Paradigm for Ischemic Preconditioning.
###end article-title 72
###begin article-title 73
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
###end article-title 73
###begin article-title 74
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor.
###end article-title 74
###begin article-title 75
Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.
###end article-title 75
###begin article-title 76
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors.
###end article-title 76
###begin article-title 77
Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia.
###end article-title 77
###begin article-title 78
A2B adenosine receptor dampens hypoxia-induced vascular leak.
###end article-title 78
###begin article-title 79
HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia.
###end article-title 79
###begin article-title 80
###xml 103 107 <span type="species:ncbi:10090">mice</span>
A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice.
###end article-title 80
###begin article-title 81
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.
###end article-title 81
###begin article-title 82
Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors.
###end article-title 82
###begin article-title 83
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine.
###end article-title 83
###begin article-title 84
###xml 140 144 <span type="species:ncbi:10090">mice</span>
Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine.
###end article-title 84
###begin article-title 85
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors.
###end article-title 85
###begin article-title 86
###xml 24 30 <span type="species:ncbi:10090">murine</span>
Characterization of the murine A1 adenosine receptor promoter, potent regulation by GATA-4 and Nkx2.5.
###end article-title 86
###begin article-title 87
###xml 80 83 <span type="species:ncbi:10116">rat</span>
The mechanism by which adenosine and cholinergic agents reduce contractility in rat myocardium. Correlation with cyclic adenosine monophosphate and receptor densities.
###end article-title 87
###begin article-title 88
Species comparison of adenosine A1 receptors in isolated mammalian atrial and ventricular myocardium.
###end article-title 88
###begin article-title 89
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.
###end article-title 89
###begin article-title 90
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Chronotropic and vasodilatory responses to adenosine and isoproterenol in mouse heart: effects of adenosine A1 receptor overexpression.
###end article-title 90
###begin article-title 91
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Myocardial function in the working mouse heart overexpressing cardiac A1 adenosine receptors.
###end article-title 91
###begin article-title 92
Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia.
###end article-title 92
###begin article-title 93
Bradycardia after heart transplantation: reversal with theophylline.
###end article-title 93
###begin article-title 94
Cardiovascular effects of microinjection of adenosine into the nucleus tractus solitarius.
###end article-title 94
###begin article-title 95
###xml 84 88 <span type="species:ncbi:10116">rats</span>
Hypotensive effects of intravenously administered uridine and cytidine in conscious rats: involvement of adenosine receptors.
###end article-title 95
###begin article-title 96
Multiple receptor subtypes and multiple mechanisms of dilation are involved in vascular network dilation caused by adenosine.
###end article-title 96
###begin article-title 97
Characterization of adenosine receptors mediating the vasodilator effects of adenosine receptor agonists in the microvasculature of the hamster cheek pouch in vivo.
###end article-title 97
###begin article-title 98
In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist.
###end article-title 98
###begin p 99
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 99
###begin p 100
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The present study is supported by United States National Institutes of Health grant R01-HL092188 and Foundation for Anesthesia Education and Research (FAER) Grants to HKE and TE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 100

